- Home
- Publications
- Publication Search
- Publication Details
Title
Trial watch
Authors
Keywords
-
Journal
OncoImmunology
Volume 2, Issue 6, Pages e24612
Publisher
Informa UK Limited
Online
2013-05-30
DOI
10.4161/onci.24612
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF-Coding Oncolytic Adenovirus
- (2013) A. Kanerva et al. CLINICAL CANCER RESEARCH
- Oncolytic measles virus strains as novel anticancer agents
- (2013) Pavlos Msaouel et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Decoding cell death signals in liver inflammation
- (2013) Catherine Brenner et al. JOURNAL OF HEPATOLOGY
- Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
- (2013) Jeong Heo et al. NATURE MEDICINE
- Blockade of the PD-1 pathway enhances the efficacy of adoptive cell therapy against cancer
- (2013) Weiyi Peng et al. OncoImmunology
- Trial watch
- (2013) Laura Senovilla et al. OncoImmunology
- Trial watch
- (2013) Laurie Menger et al. OncoImmunology
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol
- (2012) Karsten Geletneky et al. BMC CANCER
- Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus
- (2012) I. Diaconu et al. CANCER RESEARCH
- Oncolytic Immunotherapy of Advanced Solid Tumors with a CD40L-Expressing Replicating Adenovirus: Assessment of Safety and Immunologic Responses in Patients
- (2012) S. Pesonen et al. CANCER RESEARCH
- Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies
- (2012) E. M. Karapanagiotou et al. CLINICAL CANCER RESEARCH
- Recent Clinical Experience with Oncolytic Viruses
- (2012) O. G. Donnelly et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Oncolytic HSV-1 Virotherapy: Clinical Experience and Opportunities for Progress
- (2012) Balveen Kaur et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- REO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin®) in patients with advanced solid tumors
- (2012) Don G. Morris et al. INVESTIGATIONAL NEW DRUGS
- A First in Human Phase 1 Study of CG0070, a GM-CSF Expressing Oncolytic Adenovirus, for the Treatment of Nonmuscle Invasive Bladder Cancer
- (2012) James M. Burke et al. JOURNAL OF UROLOGY
- Phase II Trial of Intravenous Administration of Reolysin® (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma
- (2012) Evanthia Galanis et al. MOLECULAR THERAPY
- The Efficacy Versus Toxicity Profile of Combination Virotherapy and TLR Immunotherapy Highlights the Danger of Administering TLR Agonists to Oncolytic Virus-treated Mice
- (2012) Diana M Rommelfanger et al. MOLECULAR THERAPY
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Oncolytic Effects of a Novel Influenza A Virus Expressing Interleukin-15 from the NS Reading Frame
- (2012) Marijke van Rikxoort et al. PLoS One
- How imiquimod licenses plasmacytoid dendritic cells to kill tumors
- (2012) Martin Holcmann et al. OncoImmunology
- Trial Watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Viral antigen mediated NKp46 activation of NK cells results in tumor rejection via NK-DC crosstalk
- (2012) Fay Chinnery et al. OncoImmunology
- Combination of vaccine and immune checkpoint inhibitor is safe with encouraging clinical activity
- (2012) Ravi A Madan et al. OncoImmunology
- Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer
- (2012) Helene Pere et al. OncoImmunology
- Chemoimmunotherapy as long-term maintenance therapy for cancer
- (2012) Nejat K. Egilmez et al. OncoImmunology
- Parvoviruses-tools to fine-tune anticancer immune responses
- (2012) Svitlana P. Grekova et al. OncoImmunology
- Virus infections in tumors pave the way for tumor-directed DC-vaccines
- (2012) Norman Woller et al. OncoImmunology
- Virotherapy, gene transfer and immunostimulatory monoclonal antibodies
- (2012) José I. Quetglas et al. OncoImmunology
- TLR2 ligation protects effector T cells from regulatory T-cell mediated suppression and repolarizes T helper responses following MVA-based cancer immunotherapy
- (2012) Laurent Amiset et al. OncoImmunology
- Oncolytic adenoviruses
- (2012) Vincenzo Cerullo et al. OncoImmunology
- Trial Watch: Monoclonal antibodies in cancer therapy
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Trial Watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Trial Watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2012) Laura Senovilla et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy
- (2012) Erika Vacchelli et al. OncoImmunology
- Targeting PD-1/PD-L1 interactions for cancer immunotherapy
- (2012) Laurence Zitvogel et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Improving the outcome of adoptive cell transfer by targeting tumor escape
- (2012) Karen M. Kaluza et al. OncoImmunology
- Enhancing VSV oncolytic activity with an improved cytosine deaminase suicide gene strategy
- (2011) S Leveille et al. CANCER GENE THERAPY
- Expressing human interleukin-15 from oncolytic vesicular stomatitis virus improves survival in a murine metastatic colon adenocarcinoma model through the enhancement of anti-tumor immunity
- (2011) K B Stephenson et al. CANCER GENE THERAPY
- The emerging role of viruses in the treatment of solid tumours
- (2011) M.G. Bourke et al. CANCER TREATMENT REVIEWS
- Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
- (2011) L Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- Enhanced Safety Profiles of the Telomerase-Specific Replication-Competent Adenovirus by Incorporation of Normal Cell-Specific microRNA-Targeted Sequences
- (2011) K. Sugio et al. CLINICAL CANCER RESEARCH
- Oncolytic poliovirus against malignant glioma
- (2011) Christian Goetz et al. Future Virology
- Retargeting Vesicular Stomatitis Virus Using Measles Virus Envelope Glycoproteins
- (2011) Camilo Ayala-Breton et al. HUMAN GENE THERAPY
- Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors
- (2011) Sari Pesonen et al. INTERNATIONAL JOURNAL OF CANCER
- Pseudotyping Vesicular Stomatitis Virus with Lymphocytic Choriomeningitis Virus Glycoproteins Enhances Infectivity for Glioma Cells and Minimizes Neurotropism
- (2011) A. Muik et al. JOURNAL OF VIROLOGY
- Precise Scheduling of Chemotherapy Primes VEGF-producing Tumors for Successful Systemic Oncolytic Virotherapy
- (2011) Timothy Kottke et al. MOLECULAR THERAPY
- Optimizing DC Vaccination by Combination With Oncolytic Adenovirus Coexpressing IL-12 and GM-CSF
- (2011) Song-Nan Zhang et al. MOLECULAR THERAPY
- A Mechanistic Proof-of-concept Clinical Trial With JX-594, a Targeted Multi-mechanistic Oncolytic Poxvirus, in Patients With Metastatic Melanoma
- (2011) Tae-Ho Hwang et al. MOLECULAR THERAPY
- Mitotic catastrophe: a mechanism for avoiding genomic instability
- (2011) Ilio Vitale et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
- (2011) B. Diop-Frimpong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer
- (2010) A Nakao et al. CANCER GENE THERAPY
- Identification of the ENT1 Antagonists Dipyridamole and Dilazep as Amplifiers of Oncolytic Herpes Simplex Virus-1 Replication
- (2010) B. J. Passer et al. CANCER RESEARCH
- Myxoma Virus Virotherapy for Glioma in Immunocompetent Animal Models: Optimizing Administration Routes and Synergy with Rapamycin
- (2010) X. Lun et al. CANCER RESEARCH
- Illicit survival of cancer cells during polyploidization and depolyploidization
- (2010) I Vitale et al. CELL DEATH AND DIFFERENTIATION
- A Phase I Study of a Tropism-Modified Conditionally Replicative Adenovirus for Recurrent Malignant Gynecologic Diseases
- (2010) K. J. Kimball et al. CLINICAL CANCER RESEARCH
- Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck
- (2010) K. J. Harrington et al. CLINICAL CANCER RESEARCH
- Novel oncolytic viruses: Riding high on the next wave?
- (2010) Marianne M. Stanford et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Phase I/II Study of Oncolytic Herpes Simplex Virus NV1020 in Patients with Extensively Pretreated Refractory Colorectal Cancer Metastatic to the Liver
- (2010) Sunil K. Geevarghese et al. HUMAN GENE THERAPY
- Enhanced oncolysis mediated by Coxsackievirus A21 in combination with doxorubicin hydrochloride
- (2010) Kathryn A. Skelding et al. INVESTIGATIONAL NEW DRUGS
- Transcriptional and Translational Dual-regulated Oncolytic Herpes Simplex Virus Type 1 for Targeting Prostate Tumors
- (2010) Cleo YF Lee et al. MOLECULAR THERAPY
- Hyaluronidase Expression by an Oncolytic Adenovirus Enhances Its Intratumoral Spread and Suppresses Tumor Growth
- (2010) Sonia Guedan et al. MOLECULAR THERAPY
- Delivering nanomedicine to solid tumors
- (2010) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress
- (2010) I Martins et al. ONCOGENE
- Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
- (2009) Howard L. Kaufman et al. ANNALS OF SURGICAL ONCOLOGY
- Antitumor Activity of an Oncolytic Adenoviral-CD40 Ligand (CD154) Transgene Construct in Human Breast Cancer Cells
- (2009) E. M. Gomes et al. CLINICAL CANCER RESEARCH
- Reovirus-based therapy for cancer
- (2009) Kevin Kelly et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Genetically engineered Newcastle disease virus for malignant melanoma therapy
- (2009) D Zamarin et al. GENE THERAPY
- Chemical Modification with High Molecular Weight Polyethylene Glycol Reduces Transduction of Hepatocytes and Increases Efficacy of Intravenously Delivered Oncolytic Adenovirus
- (2009) Konstantin Doronin et al. HUMAN GENE THERAPY
- Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
- (2009) Neil N. Senzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Myxoma Virus Expressing Interleukin-15 Fails To Cause Lethal Myxomatosis in European Rabbits
- (2009) J. Liu et al. JOURNAL OF VIROLOGY
- Attenuation of Vesicular Stomatitis Virus Encephalitis through MicroRNA Targeting
- (2009) E. J. Kelly et al. JOURNAL OF VIROLOGY
- The highly attenuated oncolytic recombinant vaccinia virus GLV-1h68: comparative genomic features and the contribution of F14.5L inactivation
- (2009) Qian Zhang et al. MOLECULAR GENETICS AND GENOMICS
- A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid Tumors
- (2009) John Nemunaitis et al. MOLECULAR THERAPY
- Conditional and reversible disruption of essential herpesvirus proteins
- (2009) Mandy Glaß et al. NATURE METHODS
- Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors
- (2008) B Yaacov et al. CANCER GENE THERAPY
- A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer
- (2008) L. Vidal et al. CLINICAL CANCER RESEARCH
- Intratumoral Coadministration of Hyaluronidase Enzyme and Oncolytic Adenoviruses Enhances Virus Potency in Metastatic Tumor Models
- (2008) S. Ganesh et al. CLINICAL CANCER RESEARCH
- Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus
- (2008) J Foloppe et al. GENE THERAPY
- Potential for efficacy of the oncolytic Herpes simplex virus 1716 in patients with oral squamous cell carcinoma
- (2008) Alastair T. M. Mace et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Evaluation of IRES-mediated, cell-type-specific cytotoxicity of poliovirus using a colorimetric cell proliferation assay
- (2008) Xiaoyi Yang et al. JOURNAL OF VIROLOGICAL METHODS
- Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
- (2008) Byeong-Ho Park et al. LANCET ONCOLOGY
- A let-7 MicroRNA-sensitive Vesicular Stomatitis Virus Demonstrates Tumor-specific Replication
- (2008) Robert E Edge et al. MOLECULAR THERAPY
- A Herpes Oncolytic Virus Can Be Delivered Via the Vasculature to Produce Biologic Changes in Human Colorectal Cancer
- (2008) Yuman Fong et al. MOLECULAR THERAPY
- Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBM
- (2008) James M Markert et al. MOLECULAR THERAPY
- Chemical control of protein stability and function in living mice
- (2008) Laura A Banaszynski et al. NATURE MEDICINE
- Engineering microRNA responsiveness to decrease virus pathogenicity
- (2008) Elizabeth J Kelly et al. NATURE MEDICINE
- Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded
- (2008) Roberto Cattaneo et al. NATURE REVIEWS MICROBIOLOGY
- Viral Control of Mitochondrial Apoptosis
- (2008) Lorenzo Galluzzi et al. PLoS Pathogens
- Development of PEGylated adenovirus vector with targeting ligand
- (2007) Yusuke Eto et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Virotherapy of Ovarian Cancer With Polymer-cloaked Adenovirus Retargeted to the Epidermal Growth Factor Receptor
- (2007) Joanne Morrison et al. MOLECULAR THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started